key: cord-0716495-725hkf0n
authors: Yang, Ruhao; Yang, Haizhen; Wei, Jie; Li, Wenqiang; Yue, Fang; Song, Yan; He, Xin; Hu, Ke
title: Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach
date: 2021-10-14
journal: Front Pharmacol
DOI: 10.3389/fphar.2021.717652
sha: f03067c0cd944792d85676a524584cc785420662
doc_id: 716495
cord_uid: 725hkf0n

Background and Purpose: Sepsis is a life-threatening condition associated with secondary multiple organ injury. Acute lung injury (ALI) caused by sepsis has high morbidity and mortality in critical care units. Lianhua Qingwen (LHQW) is a traditional Chinese medicine composing of 11 herbs and 2 medicinal minerals. LHQW exhibits anti-inflammatory activity and is effective in treating pneumonia. Our study aimed to evaluate the effect of LHQW on sepsis-induced ALI and its underlying mechanism. Materials and Methods: A network pharmacology approach was used to predict the bioactive components and effective targets of LHQW in treating ALI. We established ALI model C57/BL6 mice via an intraperitoneal injection of LPS and inhibited p53 expression by pifithrin-α, in order to validate the mechanism by which LHQW exerted protective role in ALI. Hematoxylin-eosin staining was conducted to assess the severity of lung injury. The severity of inflammation was evaluated based on MPO (myeloperoxidase) activity. TUNEL assay was employed to detect apoptotic cells. The levels of p53 and caspase-3 were tested by immunohistochemical staining and Western blotting. The expression levels of Bcl-2, Bax, cytochrome C and caspase-9 were detected by Western blotting. Results: A total of 80 genes were associated with LHQW in the treatment of ALI. After PPI network construction, four active components (quercetin, luteolin, kaempferol and wogonin) and 10 target genes (AKT1, TP53, IL6, VEGFA, TNF, JUN, STAT3, MAPK8, MAPK1, and EGF) were found to be essential for ALI treatment. GO and KEGG analyses indicated that apoptosis pathway was mainly involved in the LHQW-ALI network. Animal experiments showed that LHQW was able to attenuate LPS-induced ALI, and medium-dose LHQW exhibited the most prominent effect. LHQW could inhibit the overexpression of p53 induced by LPS and suppress p53-mediated intrinsic apoptotic pathways by decreasing the levels of Bax, caspase-3 and caspase-9, increasing the expression of Bcl-2, and attenuating the release of cytochrome C in ALI mice. Conclusion: This study reveals that LHQW may alleviate LPS-induced ALI via inhibiting p53-mediated intrinsic apoptosis pathways.

Acute lung injury (ALI) is relatively severe lung damage with edema, hyperemia, and inflammatory cell infiltration. The annual mortality rate of ALI is 4% among all hospital admissions, which accounts for 10% of all intensive care unit (ICU) admissions (Bellani et al., 2016) . At present, there is no any specific effective treatment for ALI. Although the etiology and pathogeneis of ALI are complex, non-pulmonary sepsis is recognized as the most common predisposing factor for this disease, with an incidence rate of nearly 31% (Bersten et al., 2002) . In this study, an animal model of sepsis-induced ALI was established by directly injecting lipopolysaccharide (LPS) into mice (Chen et al., 2010) .

Lianhua Qingwen (LHQW) is a novel Chinese patent medicine, which has been commonly prescribed to treat influenza (Duan et al., 2011; Ding et al., 2017) , acute upper and lower respiratory tract infection (Dong et al., 2014) . As to COVID-19, LHQW also exhibits a good performance (Hu et al., 2021) . LHQW derives from three classical prescriptions, such as "Maxing Shigan-Tang" in Han dynasty, "Da Huang" in Ming dynasty and "Yinqiao-San" in Qing dynasty. LHQW consists of 11 herbs and two medicinal minerals, including In the theory of traditional medicine (TCM), compound medicines are generally considered to exert synergistic effects on distinct targets. Besides, the complex etiologies also suggest that a combination of medicines may play better therapeutic activities if the dosage, proportion and compatibility of the compounds are optimized. Therefore, we believe that the therapeutic effects of TCM can benefit from the synergistic actions of compound medicines.

Network pharmacology is a novel approach to elucidate the complex pathophysiological progress by assessing the interactions among herbs, components, targets genes and diseases (Hopkins, 2007) , which aids in understanding the instinct rules of complex formulas and revealing the multiple targets for TCM actions (Kibble et al., 2015) . In this research, we utilized the network pharmacology approach to predict the effective targets between LHQW and ALI. We systematically demonstrated that apoptotic signal transduction in biological processes was crucial pathway for LHQW in the treatment of ALI through Gene Ontology (GO) enrichment. Moreover, TP53 was identified as one of 10 key genes according to protein-protein interaction (PPI) network analysis. These results indicated that LHQW might protect lung tissues from ALI by inhibiting p53mediated apoptosis. In mammalian cells, P53 transcriptional activation causes cell growth arrest and induces cell apoptosis (Liu and Chen, 2006) . The p53-mediated cell apoptosis has two major pathways: extrinsic pathway and intrinsic pathway (Ashkenazi and Dixit, 1998) . The extrinsic pathway is mainly triggered by the engagement of death receptors. The intrinsic apoptosis pathways are dominated by Bax, puma and noxa, which can lead to the release of cytochrome C from mitochondria as well as the activation of caspase-3 and -9. Several studies have suggested that p53-mediated cell apoptosis may play an essential role in mediating the pathogenesis of ALI.

Based on the network pharmacology results, we observed that LHQW alleviated ALI through inhibition of p53-mediated cell apoptosis. In this study, LPS-induced ALI mouse model was built to evaluate the therapeutic effects of LHQW. Furthermore, pifithrin-α (a p53 specific inhibitor) was adopted to verify the mechanism of action of LHQW against p53-mediated cell apoptosis. Our results demonstrated that LHQW could protect the lung tissues from ALI, thus making it a promising strategy for alleviating the lung injuries caused by pathogenic factors.

LHQW were produced by Shijiazhuang Yiling Pharmaceutical Co., Ltd., China (B2001019). LHQW consists of 11 herbs and two mineral Chinese medicines. The contents and proportions, method of extraction and fingerprint of Lianhuaqingwen (UPLC) were provided (Supplementary Material).

The TCM systems pharmacology database (TCMSP, https:// tcmspw.com/tcmsp.php v2.3) (Ru et al., 2014) was used to retrieve all 13 TCM compounds in LHQW. TCMSP contains 499 herbs registered in the Chinese pharmacopoeia (2010) with 12,144 ingredients. ADME (absorption, distribution, metabolism, and excretion) screening was performed to determine bioactive components that meet the following two requirements: 1) oral bioavailability ≥30% and drug-likeness ≥0.18. The target gene of bioactive compounds were retrieved from prior literature and TCM system pharmacology database. UniPortKB (https://www. uniprot.org) was used to standardize target proteins and covert protein names into gene names under "Homo sapiens" conditions.

Herb-component-target network was constructed using the Cytoscape v3.7.1 (Shannon et al., 2003) . There were 80 common targets of the main active ingredients and acute lung injury. To build a PPI network, the shared targets were processed by STRING v11.0b (https://string-db.org/) with a limitation to "Homo sapiens" and confidence score ≥0.7. The PPI network of 80 overlapped targets based on STRING data was generated by Cytoscape v3.7.1, which contained the degree values of nodes. The herb-component-overlapped target network was constructed by Cytoscape v3.7.1 to determine the major ingredients of LHQW for treating ALI. Molecular Complex Detection (MCODE), a Cytoscape plugin, was used to pick out the major dense region in the network of 80 overlapped target gene. The following settings were used: Degree Cut-off 2, Node Score Cut-off 0.2, K-Core 2, and Max Depth 100. The seed genes were obtained in protein clusters with highest degree of MCODE Score.

To identify the functional characteristics of the putative targets for LHQW in ALI. GO enrichment and KEGG pathway analyses were performed by Metascape (http://metascape.org/; v3.5; last updated date on 2020-09-16), which contained a series of bioinformatics tools for analyzing gene/protein functions and improving pre-clinical decisions (Zhou et al., 2019) . The "H. sapiens" and p-value cut-off of <0.01 were adjusted to obtain the analysis results. Cytoscape v3.7.1 was used to construct the pathway-target network.

C57/BL6 mice (male, 8-10 weeks old) were supplied by Charles River Labs (Beijing, China). The ethical approval for animal experiments was obtained from the Animal Ethics Committee of Wuhan University, Wuhan, China (2019K-K081). Mice were maintained under specific pathogen-free (SPF) condition at 23 ± 2°C over a 12-h day/night cycle, with free access to water and food. A week of adjustable feeding was conducted prior to LHQW administration.

All mice were categorized into seven groups as follows: 1) control group (n 4); 2) LPS (Sigma, L2630; 10 mg) group (5 mg/kg, n 4); 3) LPS with low-dose LHQW (700 mg/kg/day, n 4); 4) LPS with medium-dose LHQW (1,400 mg/kg/day, n 4); 5) LPS with high-dose LHQW (2,800 mg/kg/day; n 4); 6) LPS with pifithrin-α (TargetMol, T2707; 5 mg) group (3 mg/kg/ day, n 4); and 7) LPS with pifithrin-α and medium-dose LHQW (n 4). LHQW was administrated by gavage for six successive days. On the fifth day, pifithrin-α was given by intraperitoneal injection for two successive days. On the sixth day, the mice were subjected to an intraperitoneal injection of LPS and then sacrificed after 24 h. The left lung tissues were snap-frozen in liquid nitrogen and kept at −80°C for Western blotting; while the right lung tissues were fixed in 10% paraformaldehyde for histological, immunohistochemical and TUNEL staining.

After fixing in 10% paraformaldehyde and embedding in paraffin, the lung sections (4 μm) were stained with hematoxylin and eosin (HE). The histopathological changes in lung tissues were examined using an optical microscope. Lung injury score (Matute-Bello et al., 2011) was used to measure the histological evidence of tissue injury.

The lung sections in each sample (3 μm) were deparaffinized and rehydrated with turpentine, ethanol and water. The sections were incubated overnight at 4°C with p53 polyclonal antibody (1:250 dilution; Immunoway, YT3528), caspase-3 polyclonal antibody (1:250 dilution; Poteintech, 19677-1-AP) or MPO (myeloperoxidase) (1:1000 dilution; Abcam, ab208670). On the next day, the sections were exposed to the corresponding secondary antibody at 37°C for 1 h. The positive cells were counted in three fields of a lung section.

The lung sections in each sample (3 μm) were deparaffinized and rehydrated with ethanol at graded concentrations of 100, 95, and 75% (v/v) each for 5 min. After rinsing with distilled water, proteinase K (10 μg/ml, Roche) was added to the lung sections for 10 min, and then washed again for three times in Trisbuffered saline (TBS; each time for 5 min). Equilibrium solution was added to each lung section for 10 min. TUNEL assay kit (Roche, 11684795910) was employed to determine the apoptotic rate of lung tissue. DAPI (Roche, 216276) was used to stain the nucleus. TUNEL-positive cells were counted in three fields of a lung section.

After scrapping, the lung tissue was lysed in RIPA lysis buffer for 30 min to isolate total protein. The lysate was transferred into an EP tube and centrifuged for 5 min at 12,000 rpm/min. Total protein content was assessed by BCA assay kit (Thermo Fisher Scientific). The protein samples were separated on 12% sodium dodecyl sulfate Tris-HCl gels according to their molecular weight, and then immobilized onto PVDF membranes via electroblotting. After blocking with 5% skimmed milk in TBS containing 0.1% Tween (TBST) for 1 h, the membrane was exposed to the primary antibody against p53 (Immunoway, YT3528), Bcl-2 (Biorbyt, orb10173), Bax (Proteintech, 50599-2-Ig), cytochrome C (immunoway, YM3402), caspase-3 (Proteintech, 19677-1-AP), caspase-9 (Proteintech, 66169-1-AP), VDAC (Abcepta, AP6627A) or GAPDH (GOOD HERE, AB-P-R 001) at 4°C for 24 h. After rinsing in TBST for five times (each for 5 min), the membrane was exposed to the corresponding secondary antibody for 2 h at 37°C. Super ECL Plus (Applygen Technologies, P1050) was added onto the membranes to visualize the protein bands. The intensity of each band was measured by ImageJ software.

All experiments were repeated for three times. All values were shown as mean ± SD. One-way ANOVA followed by Tukey's Frontiers in Pharmacology | www.frontiersin.org

October 2021 | Volume 12 | Article 717652 post-hoc test was performed for comparing the differences between groups. p < 0.05 was considered statistically significant. All statistical data were calculated using the GraphPad Prism 8 software.

There were 223 active compounds in LHQW after eliminating the duplicates from TCMSP database. A total of 38 active compounds were identified from BLG, 19 from KXR, 16 from DH, 92 from GC, 7 from GZ, 11 from GHX, 23 from JYH, 23 from LQ, 23 from MH, 7 from YXC, and 3 form HJT (Supplementary Table S1 ).

Among the active compounds, 188 compounds contained the information about the target genes. There were 21 common ingredients for at least two herbs, in which two ingredients (mairin, luteolin) were common for three herbs, two ingredients (sitosterol, stigmasterol) were common for four herbs, one ingredient (beta-sitosterol) was common for five herbs, one ingredient (quercetin) was common for six herbs, and one ingredient (kaempferol) was common for seven herbs (Supplementary Figure S1 ). Finally, we identified 254 predicted targets after eliminating the duplicates (Supplementary Table S2 ).

There were a total of 254 potential targets in LHQW and 670 ALIrelated genes based on OMIM and GeneCards databases, and 80 overlapping genes were identified from the above information ( Figure 1A) . The 80 overlapping genes were imported into STRING to establish a compound-disease co-targets PPI network containing 80 nodes and 849 edges ( Figure 1B) . We identified that AKT1, TP53, IL6, VEGFA, TNF, JUN, STAT3, MAPK8, MAPK1, and EGF were pivotal genes with high degree values of ≥40 (Supplementary Table S3 ). Table S4 ). The pathways, such as PI3K-Akt signaling pathway (hsa04151), complement and coagulation cascades (hsa04610), NF-κB signaling pathway (ko04065), cytokine-cytokine receptor interaction (ko04060), mitophagy-animal (ko04137) and TGF-β signaling pathway (ko04350), were related to ALI caused by LPS ( Figure 2B ).

The information about 80 overlapping genes from STRING database were imported into Cytoscape for further analysis. Table S5 ).

To identify the most effective component in LHQW for ALI treatment, the component-overlapping target genes PPI network was established, and the degree value was calculated through network analysis. We found that quercetin was the major component in LHQW with the highest degree, followed by luteolin, kaempferol and wogonin, all with degree values >20 (Supplementary Figure S2 ).

To determine the effects of LHQW on LPS-induced ALI, we observed pathological and inflammatory changes in the lung section of ALI model mice. LHQW pretreatment was conducted before an intraperitoneal injection of LPS (5 mg/kg). Lung tissue were harvested after 24 h and subjected to HE staining and MPO-positive neutrophil Frontiers in Pharmacology | www.frontiersin.org October 2021 | Volume 12 | Article 717652 5 assessment. There were significant pathological changes in the mice challenged with LPS. Thickened alveolar wall, increased neutrophils in the alveolar and interstitial space, and congestion of pulmonary capillary were observed in the LPS-challenged mice. Treatment with high-or medium-dose LHQW significantly alleviated the pathological changes and improved lung injury score in the LPS-challenged mice. However, there was no difference in pathological changes between the mice pretreated with high-and medium-dose LHQW ( Figures 4A,C) . The expression of MPO was also remarkably increased after LPS treatment, and then reduced after pretreatment with high-and medium-dose LHQW, which were consistent with the results of HE staining ( Figures 4B,D) .

To validate the key target gene p53 of LHQW predicted from the PPI networks, LPS-induced ALI mice were intraperitoneally injected with 3 mg/kg pifithrin-α (p53 inhibitor) for two successive days. We observed an increase in the expression of p53 in LPS-challenged mice by immunohistochemical staining, but the expression was decreased in mice treated with mediumdose LHQW or pifithrin-α ( Figures 5A,D) . Besides, LHQW and pifithrin-α also attenuated the pathological changes and MPOpositive neutrophils in the lung tissues of LPS-challenged mice. The decreased p53 expression and alleviated pathological changes were more obvious in mice treated with a combination of LHQW and pifithrin-α compared with those treated with LHQW or pifithrin-α alone. Although pifithrin-α could attenuate pathological injuries and inflammation in the lung tissues of LPS-challenged mice, the effects were less obvious in mice treated with medium-or high-dose LHQW ( Figures 4A,B) .

To elucidate the protective mechanism of LHQW in LPS-induced ALI, we focused on apoptosis signaling pathway that interacts with many other signaling pathways to regulate biological processes. The immunohistochemistry results demonstrated that LPS remarkably upregulated the expression of caspase-3, and medium-dose LHQW could suppress the increased expression of caspase-3 ( Figures 5B,E) . Moreover, TUNEL staining results showed that apoptotic cells were increased after LPS challenge, and medium-dose LHQW significantly attenuated LPS-induced apotosis ( Figures 5C,F) . We also found that pifithrin-α could decrease caspase-3 expression and apoptotic cells. The mice treated with a combination of mediumdose LHQW and pifithrin-α exhibited the lowest levels of caspase-3 expression and apoptotic cells.

Given that LHQW could alleviate ALI damage by downregulating p53 expression and inhibiting apoptosis, the relationship between p53 and apoptosis was further investigated. In addition, p53 has been shown to mediate intrinsic apoptosis pathways. Thus, we assessed whether LHQW can attenuate LPS-induced ALI by inhibiting intrinsic apoptosis pathways caused by p53. The activities of intrinsic apoptosis-related proteins (p53, Bcl-2, Bax, cytochrome C, caspase-3 and caspase-9) were determined FIGURE 3 | Cluster of the 80 overlapping genes-containing PPI network. Three clusters were identified. (A-C) stand for Clusters 1, 2, and 3, respectively. Cluster 1 had highest score of 15.238, and TP53 was identified as the seed gene. Cluster 2 had the score of 10.526, and MAPK8 was the seed gene. Cluster 3 had the score of 4.0, and MDM2 was the seed gene.

Frontiers in Pharmacology | www.frontiersin.org October 2021 | Volume 12 | Article 717652 6 by Western blotting. The data revealed that LPS promoted the expression of p53, Bax, cytochrome C, caspase-3 and caspase-9, while suppressed the expression of Bcl-2 ( Figures 6A-G) in the cytoplasm and inhibited the expression of cytochrome C in the mitochondria (Figures 6H-J) . Interestingly, these effects were blunted by medium-dose LHQW and pifithrin-α, and it was more The percentages of Tunel-positive cells were counted in three fields of a lung section. LPS, 5 mg/kg; LHQW, 1,400 mg/kg/day; p53 inhibitor, pifithrin-α (3 mg/kg/day). Data are shown as mean ± SD from one-way ANOVA followed by Tukey's post-hoc test. *p < 0.05, versus Control; # p < 0.05, versus LPS.

Frontiers in Pharmacology | www.frontiersin.org October 2021 | Volume 12 | Article 717652 8 obvious in mice treated with combination therapy. Our findings imply that LHQW exhibits a protective effect on ALI mice by inhibiting p53-mediated intrinsic apoptosis pathways.

In this study, we found that medium-and high-dose LHQW could alleviate LPS-induced ALI in vivo. To elucidate the mechanisms of action, a network pharmacology-based approach was carried out. We found that apoptosis was the most important signaling pathway in biological processes and TP53 was one of 10 key genes for mediating the therapeutic effect of LHQW on ALI. More importantly, the apoptosis pathway is mainly regulated by p53. Therefore, we focused on the importance of p53-mediated apoptosis in the treatment progress of LPS-induced ALI. The results indicated that LHQW could ameliorate LPS-induced ALI by suppressing p53-mediated intrinsic apoptosis pathways in vivo (Figure 7) .

ALI caused by sepsis is accounted for at least 40% of all cases . The lung is not only the earliest organ that gets affected but also contributes to the highest incidence for organ failure induced by sepsis. However, there is no effective treatment to stop the rapid progression of sepsis-induced ALI. Accumulating evidence has indicated that LHQW exerts Comparison of the gray values of cytochrome C in mitochondria and cytosol in mice by ImageJ software (with GAPDH and VADC loading controls). LPS, 5 mg/kg; LHQW, 1,400 mg/kg/day; p53 inhibitor, pifithrin-α (3 mg/kg/day). Data are shown as mean ± SD from one-way ANOVA followed by Tukey's post-hoc test. *p < 0.05, versus Control; # p < 0.05, versus LPS.

Frontiers in Pharmacology | www.frontiersin.org

October 2021 | Volume 12 | Article 717652 9 therapeutic effects on acute respiratory infections caused by viruses. Compared with oseltamivir, LHQW could shorten the duration of symptoms caused by influenza, including fever, cough, sore throat, and body ache . In an animal study, LHQW could also attenuate lung injury and viral load (Gao et al., 2020) . LHQW also demonstrated satisfactory effects during the SARS outbreak in 2003 (Tong et al., 2004) . Since December 2019, COVID-19 has emerged as a pandemic outbreak with greatly pathogenicity and transmissibility (Zhu et al., 2020) , and several studies have shown that LHQW could reduce the course of COVID-19 and relieve the symptoms (Xiao et al., 2020) . In Vero E6 cells, LHQW effectively blocked the replication of SARS-CoV-2 and decreased the production of pro-inflammatory cytokines (Runfeng et al., 2020) . However, it remains elusive whether LHQW also exerts a protective effect on sepsis-induced pneumonia. In this study, the sepsis-induced ALI mouse model was constructed by an intraperitoneal injection of LPS. We found that medium-and high-dose LHQW could attenuate LPS-induced ALI in mice.

To further elucidate the mechanism by which LHQW prevented LPS-induced ALI, we analyzed active component and target genes of LHQW retrieved from TCMSP database, and successfully screened out 80 overlapping genes by intersecting with ALI disease target genes from OMIM and GeneCards databases. Among them, AKT1, TP53, IL6, VEGFA, TNF, JUN, STAT3, MAPK8, and MAPK1 were key genes with high degree value of >40. Akt1 is a family member of serine/ threonine protein kinases that can reduce neutrophil recruitment and prevent ALI occurrence (Liu et al., 2013) . Recent research has demonstrated that Akt1 is a key target for LHQW to treat COVID-19 . IL-6 and TNF-α are released by the activated neutrophils and macrophages, and are well recognized as proinflammatory cytokines and biomarkers for the diagnosis of sepsis (Aggarwal, 2003; Molano Franco et al., 2019) . VEGFA, an isoform of the VEGF family, can induce physiological and pathological angiogenesis, which in turn promotes lung vessel permeability and aggravates LPS-induced ALI (Tang et al., 2016) . Moreover, at the transcriptional level, Jun can enhance the production of inflammatory cytokines in sepsis-induced ALI (Cai et al., 2019) , and STAT3 activated by IL-6 also contributes to the progression of ALI (Zhao et al., 2016) . In addition to the key genes identified by PPI construction, GO analysis showed that apoptosis signaling pathways played a vital role in the biological processes of LHQW-ALI network. Compelling evidence shows that excessive apoptosis of alveolar epithelial cells exaggerates ALI (Galani et al., 2010; Hu et al., 2014) , and inhibition of cell apoptosis effectively protects the lung tissues from ALI (Aggarwal et al., 2012) . Apart from the regulation of inflammatory response, p53 mostly functions in acute injury by regulating apoptosis and cell arrest. In liver injury model, San huang yin chi decoction has been reported to improve hepatic injury by downregulating p53-mediated apoptosis signaling pathway (Diao et al., 2017) . In acute lung injury, Physalis alkekengi L. var. franchetii can also alleviate LPS-induced ALI by targeting p53 and inhibiting cell apoptosis . Our study revealed that LPS increased the expression level of p53, activated the intrinsic apoptotosis pathways by upregulating Bax, caspase-3 and caspase-9 expression, and releasing cytochrome C from the mitochondria to the cytosol in the lung tissue of sepsis-induced ALI. Apart from the intrinsic apoptosis pathway, p53 could also mediate the extrinsic apoptosis pathway such as the activation of Fas (Nagata and Golstein, 1995) , DR5 (Wu et al., 1997) , and PERP (Singaravelu et al., 2009) . A previous study has shown that Fas/FasL-dependent apoptosis also participates in the pathogenic mechanism of LPS-induced ALI (Kitamura et al., 2001) . Thus, investigating the extrinsic apoptosis pathways regulated by p53 will allow a more comprehensive understanding of p53-mediated apoptosis in LPS-induced ALI. However, some reports have shown that p53 plays a protective role in ALI through the inhibition of inflammatory responses (Liu et al., 2009 ) and enhancement of endothelial barrier function (Barabutis et al., 2018) . These studies are focusing on the inflammatory cells and endothelial cells. It is worth noting that different administration routes and dosage forms may lead to a discrepancy in results.

In addition, compared with pifithrin-α, medium-and highdose LHQW displayed better effects on LPS-induced ALI, suggesting that the therapeutic effects of LHQW on sepsisinduced ALI are not limited to p53-mediated apoptosis pathway only. According to the KEGG results, several classical pathways, such as PI3K-Akt signaling pathway (Shi et al., 2019) , NF-κB signaling pathway (Ju et al., 2018) , cytokine-cytokine receptor interaction (Gouda and Bhandary, 2019) , mitophagy-animal , TGF-β signaling pathway and complement and coagulation cascades (Chimenti FIGURE 7 | Mechanisms underlying the inhibitory effect of LHQW on p53-mediated apoptosis in ALI induced by LPS. Under normal conditions, Bcl-2 constant interacted with Bax and inhibited Bax from accumulating at the mitochondrial outer membrane, thus suppressing cell apoptosis. Under LPS stimulation, p53 and its downstream target Bax were upregulated and translocated to mitochondrial outer membrane to form a homodimer. On the other hand, p53 was able to permeabilize the outer mitochondrial membrane by binding to Bcl-2. The accumulation of Bax on the outer mitochondrial membrane could promote the release of cytochrome C, which in turn led to the formation of apoptosomes (Apaf-1, cytochrome C and caspase-9). Once activated, the effector caspases could induce cell apoptosis. LHQW treatment could attenuate LPS-induced apoptosis by downregulating p53 expression.

Frontiers in Pharmacology | www.frontiersin.org October 2021 | Volume 12 | Article 717652 et al., 2017), were regarded as the potential targets of LHQW for treating LPS-induced ALI. Furthermore, quercetin, luteolin, kaempferol, and wogonin were identified as the active components of LHQW against LPSinduced ALI. All these natural active components are reported to exhibit antioxidative stress, reduce inflammatory cytokines, and inhibit neutrophil recruitment (Chen et al., 2012; Park et al., 2018; Wang et al., 2018) , (Yao et al., 2014) . This indicates that LHQW has the pharmacological component bases to attenuate LPSinduced ALI.

In this study, a network pharmacology strategy was applied to predict the bioactive ingredients, effective targets, target genes, and signaling pathways of LHQW in the treatment of ALI. The significantly enriched biological process GO terms indicated that anti-apoptotic signaling molecules might be the most important pharmacological mechanism for LHQW in ALI. Moreover, we validated the results of network pharmacology approach in LPS-induced ALI mice treated with/without LHQW. Our findings revealed that LHQW was able to alleviate LPS-induced ALI in vivo. Furthermore, we observed that LHQW had protective effects on LPS-induced ALI via inhibiting p53-mediated intrinsic apoptotic pathways. In addition to p53-mediated apoptosis pathway, other signaling pathways may also contribute to the efficacy of LHQW, which await further studies.

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

The animal study was reviewed and approved by the Animal Ethics Committee of Wuhan University, Wuhan, China (2019K-K081).

RY: Writing, conception and design; HY: Animal model construction; JW: Editing and data curation; WL: Editing and data curation; FY: Western blot and HE staining; YS: Immunohistochemistry and TUNEL staining; XH: Data collection; KH: Conception, design, supervision and funding. 

Glutathione Supplementation Attenuates Lipopolysaccharide-Induced Mitochondrial Dysfunction and Apoptosis in a Mouse Model of Acute Lung Injury

Signalling Pathways of the TNF Superfamily: A Double-Edged Sword

Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes

Death Receptors: Signaling and Modulation

Wildtype P53 Enhances Endothelial Barrier Function by Mediating RAC1 Signalling and RhoA Inhibition

Epidemiology, Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Australian, and New Zealand Intensive Care Society Clinical Trials, G. (Incidence and Mortality of Acute Lung Injury and the Acute Respiratory Distress Syndrome in Three Australian States

Frontiers in Pharmacology | www.frontiersin.org

Astaxanthin Prevents against Lipopolysaccharide-Induced Acute Lung Injury and Sepsis via Inhibiting Activation of MAPK/NF-κB

The Value of the Lipopolysaccharide-Induced Acute Lung Injury Model in Respiratory Medicine

Kaempferol Regulates MAPKs and NF-Κb Signaling Pathways to Attenuate LPS-Induced Acute Lung Injury in Mice

Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury

SHYCD Induces APE1/Ref-1 Subcellular Localization to Regulate the P53-Apoptosis Signaling Pathway in the Prevention and Treatment of Acute on Chronic Liver Failure

The Chinese Prescription Lianhuaqingwen Capsule Exerts Anti-influenza Activity through the Inhibition of Viral Propagation and Impacts Immune Function

Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Evid. Based Complement

Natural Herbal Medicine Lianhuaqingwen Capsule Anti-influenza A (H1N1) Trial: a Randomized, Double Blind, Positive Controlled Clinical Trial

The Role of Apoptosis in the Pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an Up-To-Date Cell-specific Review

Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection

Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and its Regulation by Curcumin

Complement C5a Exacerbates Acute Lung Injury Induced through Autophagy-Mediated Alveolar Macrophage Apoptosis

Efficacy and Safety of Lianhuaqingwen Capsules, a Repurposed Chinese Herb, in Patients with Coronavirus Disease 2019: A Multicenter, Prospective, Randomized Controlled Trial

MicroRNA-27a Alleviates LPS-Induced Acute Lung Injury in Mice via Inhibiting Inflammation and Apoptosis through Modulating TLR4/MyD88/NF-Κb Pathway

Network Pharmacology Applications to Map the Unexplored Target Space and Therapeutic Potential of Natural Products

Fas/FasL-dependent Apoptosis of Alveolar Cells after Lipopolysaccharide-Induced Lung Injury in Mice

Regulation of the P53 Transcriptional Activity

p53 Attenuates Lipopolysaccharide-Induced NF-kappaB Activation and Acute Lung Injury

Kinase AKT1 Negatively Controls Neutrophil Recruitment and Function in Mice

Telomere Shortening Activates TGF-β/Smads Signaling in Lungs and Enhances Both Lipopolysaccharide and Bleomycin-Induced Pulmonary Fibrosis

An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals

Plasma Interleukin-6 Concentration for the Diagnosis of Sepsis in Critically Ill Adults

The Fas Death Factor

Luteolin Activates ERK1/2-and Ca2+-dependent HO-1 Induction that Reduces LPS-Induced HMGB1, iNOS/NO, and COX-2 Expression in RAW264.7 Cells and Mitigates Acute Lung Injury of Endotoxin Mice

TCMSP: a Database of Systems Pharmacology for Drug Discovery from Herbal Medicines

Lianhuaqingwen Exerts Anti-viral and Anti-inflammatory Activity against Novel Coronavirus (SARS-CoV-2)

Cytoscape: a Software Environment for Integrated Models of Biomolecular Interaction Networks

PI3K/Akt Pathway-Mediated HO-1 Induction Regulates Mitochondrial Quality Control and Attenuates Endotoxin-Induced Acute Lung Injury

PERP, a P53 Proapoptotic Target, Mediates Apoptotic Cell Death in Renal Ischemia

The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses

Down-regulation of microRNA-126-5p Contributes to Overexpression of VEGFA in Lipopolysaccharide-Induced Acute Lung Injury

TCM Treatment of Infectious Atypical Pneumonia-Aa Report of 16 Cases

Protective Effect of Quercetin in LPS-Induced Murine Acute Lung Injury Mediated by cAMP-Epac Pathway

Paclitaxel Alleviated Sepsis-Induced Acute Lung Injury by Activating MUC1 and Suppressing TLR-4/nf-Κb Pathway

KILLER/DR5 Is a DNA Damage-Inducible P53-Regulated Death Receptor Gene

Network Pharmacology and Molecular Docking Analyses on Lianhua Qingwen Capsule Frontiers in Pharmacology | www

Indicate Akt1 Is a Potential Target to Treat and Prevent COVID-19

Efficacy of Huoxiang Zhengqi Dropping Pills and Lianhua Qingwen Granules in Treatment of COVID-19: A Randomized Controlled Trial

Systems Pharmacology Reveals the Mechanism of Activity of Physalis Alkekengi L. Var. Franchetii against Lipopolysaccharide-Induced Acute Lung Injury

Wogonin Prevents Lipopolysaccharide-Induced Acute Lung Injury and Inflammation in Mice via Peroxisome Proliferator-Activated Receptor Gamma-Mediated Attenuation of the Nuclear Factor-kappaB Pathway

Bcl-2 Proteins Regulate Mitophagy in Lipopolysaccharide-Induced Acute Lung Injury via PINK1/Parkin Signaling Pathway

Efficacy of Lianhuaqingwen Capsule Compared with Oseltamivir for Influenza A Virus Infection: a Meta-Analysis of Randomized

Protective Effect of Suppressing STAT3 Activity in LPS-Induced Acute Lung Injury

Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets

A Novel Coronavirus from Patients with Pneumonia in China

The authors would like to express their gratitude to EditSprings (https://www.editsprings.com/) for the expert linguistic services provided.

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2021.717652/ full#supplementary-material Supplementary Figure S1 | Herb-Component-Target Network of Lianhua Qingwen. Diamond nodes represent genes; circle nodes represent herbs; and the herb is named by acronym. Hexagon nodes of the same color that make a circle around herb represent components of the herb; and the components are named by acronym of corresponding to the herbs. Detailed information of the components are provided in Supplementary Table S1 | The remaining hexagon nodes represent a common component of two or more herbs. A, kaempferol; B, quercetin; C, betasitosterol; D1, sitosterol; D2, stigmasterol; E1, luteolin; E2, mairin; F1-F14, the common component of two herbs. The size of genes from large to small is arranged in descending order based on their degree values.Supplementary Figure